Company · CIK 1804585
NUGENEREX IMMUNO-ONCOLOGY, INC.
| CIK | 1804585 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | TX |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-06-17 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-248789 | 2020-09-14 | 2021-05-20 | 3 | |
| 333-248792 | 2020-09-14 | 2020-09-14 | 1 | |
| 333-248796 | 2020-09-14 | 2020-09-14 | 1 |
Filings
5| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-05-20 | S-1/AAmendment | 333-248789 | 0001607062-21-000134 |
| 2021-05-19 | S-1/AAmendment | 333-248789 | 0001607062-21-000131 |
| 2020-09-14 | S-1Registration filed | 333-248796 | 0001607062-20-000276 |
| 2020-09-14 | S-1Registration filed | 333-248792 | 0001607062-20-000274 |
| 2020-09-14 | S-1Registration filed | 333-248789 | 0001607062-20-000272 |